Information:
Fel:
ID
34591
Beskrivning
Evaluation of the Effect of Gemigliptin on Metabolic Endotoxemia and Lipemia Induced by High Fat Diet in Patients With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT02186080
Länk
https://clinicaltrials.gov/show/NCT02186080
Nyckelord
Versioner (1)
- 2019-01-19 2019-01-19 -
Rättsinnehavare
see on clinicaltrials.gov
Uppladdad den
19 januari 2019
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Type 2 Diabetes Mellitus NCT02186080
Eligibility Type 2 Diabetes Mellitus NCT02186080
- StudyEvent: Eligibility
Similar models
Eligibility Type 2 Diabetes Mellitus NCT02186080
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
ID.1
Item
age from 20 to 75
boolean
ID.2
Item
at least 6 months from the diagnosis of type 2 diabetes
boolean
ID.3
Item
current diabetes treatment: life style modification and/or metformin and/or sulfornylurea
boolean
ID.4
Item
no change of the diabetes treatment (drug number and dossage) in recent 3 months
boolean
ID.5
Item
hba1c 6.5% to 10%
boolean
ID.6
Item
recent cardiovascular event in 6 months
boolean
ID.7
Item
concurrent use of statin or fibrate or ezetimibe
boolean
ID.8
Item
renal failure, chronic liver disease
boolean
ID.9
Item
pregnancy or lactation
boolean
ID.10
Item
use of other dpp-4 inhibitor or glp-1 analogue in recent 3 months
boolean